Search results for "VIRUS"

showing 10 items of 5024 documents

Epstein-Barr virus is not detected in mucosal lichen planus

2018

Background Lichen planus (LP) is a chronic inflammatory, immunological, mucocutaneous disease can affect skin, genital and oral mucosa. Oral lichen planus (OLP) is the most common noninfectious, chronic inflammatory oral disease affecting 1-2% of the general adult population. World Health Organization (WHO) classifies OLP as a potentially malignant disorder. Epstein Barr virus or human herpesvirus-4, is a member of the herpes virus family and one of the most ubiquitous viruses known to human, infecting approximately 90% of the world’s adult population. The virus often infects B lymphocytes resulting in a wide spectrum of mucocutaneous and systemic diseases, ranging from mild lesions to aggr…

AdultMaleHerpesvirus 4 Humanmedicine.medical_specialtyMucocutaneous zonemedicine.disease_causeYoung Adult03 medical and health sciences0302 clinical medicinestomatognathic systemmedicineHumansSex organOral mucosaskin and connective tissue diseasesGeneral DentistryAgedAged 80 and overOral Medicine and PathologyMucous Membraneintegumentary systembusiness.industryResearchLichen Planusfood and beveragesMucous membrane030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseEpstein–Barr virusDermatologystomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASFemaleSurgeryOral lichen planusbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct c…

2000

Abstract Background: Antibodies with functional anti-Human Cytomegalovirus (HCMV) activity are likely to be involved in preventing virus dissemination and thus may contribute to minimize the clinical manifestations of infection. Objectives: To investigate the role of humoral immunity in modulating the clinical expression of primary Human Cytomegalovirus (HCMV) infection in immunocompetent persons. Study design: Neutralizing (NA) and glycoprotein B (gB)-specific antibodies were quantitated in acute-phase and late-convalescence phase sera from 19 individuals who developed either HCMV mononucleosis (12) or oligosymptomatic hepatitis (seven). Results: The levels of NA in sera drawn early after …

AdultMaleHuman cytomegalovirusAdolescentHepatitis Viral HumanMononucleosisvirusesAntibody AffinityCongenital cytomegalovirus infectionBiologyAntibodies ViralViral Envelope ProteinsNeutralization TestsVirologymedicineHumansAvidityInfectious MononucleosisChildmedicine.diseaseVirologyInfectious DiseasesChild PreschoolImmunoglobulin GCytomegalovirus InfectionsDNA ViralHumoral immunityImmunologybiology.proteinFemaleAntibodyViral hepatitisImmunocompetenceViral loadJournal of Clinical Virology
researchProduct

Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease

1998

Human cytomegalovirus (HCMV)-specific antibody responses in HIV-1 infected individuals either with or without HCMV end-organ disease were examined to determine the whether development of HCMV disease was associated with a particular deficit in the antibody response. Antiwhole HCMV, anti-glycoprotein B (gB), and neutralizing antibody levels were higher in HIV-1 infected individuals than in healthy immunocompetent subjects, particularly in patients with AIDS either with or without HCMV-associated disease. Irrespective of location and spread of HCMV disease, patients who had received anti-HCMV therapy prior to sampling exhibited significantly higher anti-gB and neutralizing antibody titers tha…

AdultMaleHuman cytomegalovirusAdolescentvirusesCytomegalovirusBiologyAntibodies ViralAntiviral AgentsViral Envelope ProteinsNeutralization TestsBetaherpesvirinaeVirologyImmunopathologymedicineHumansViremiaFluorescent Antibody Technique IndirectNeutralizing antibodyAcquired Immunodeficiency SyndromeAIDS-Related Opportunistic InfectionsAntibody titervirus diseasesbiochemical phenomena metabolism and nutritionmedicine.diseasebiology.organism_classificationVirologyCD4 Lymphocyte CountInfectious DiseasesImmunoglobulin GCytomegalovirus InfectionsImmunologyHIV-1biology.proteinFemaleViral diseaseAntibodyViral loadJournal of Medical Virology
researchProduct

Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitis

2011

AIM: To evaluate the natural history of human cytomegalovirus (HCMV) infection in a series of 28 ulcerative colitis patients in whom the search for HCMV was positive. METHODS: A series of 85 patients with moderate-severe ulcerative colitis flare-up were evaluated for a HCMV search by performing a haematoxylin and eosin stain, immunohistochemical assay and nested polymerase chain reaction on rectal biopsies. Among 85 screened patients (19 of whom were steroid resistant/dependant), 28 were positive for HCMV; after remission the patients were followed up clinically and histologically. RESULTS: Among the 22 patients with complete follow-up, in 8 (36%) patients HCMV-DNA persisted in the intestin…

AdultMaleHuman cytomegalovirusmedicine.medical_specialtyBrief ArticlevirusesCongenital cytomegalovirus infectionCytomegalovirusGastroenterologyRecurrenceInternal medicinemedicineHumansProspective StudiesColitisProspective cohort studyAntigens ViralAcute colitisAgedbusiness.industryRemission InductionGastroenterologyvirus diseasesGeneral MedicinePouchitisMiddle Agedbiochemical phenomena metabolism and nutritionmedicine.diseaseUlcerative colitisCytomegalovirus InfectionsDNA ViralImmunologyColitis UlcerativeFemalebusinessNested polymerase chain reactionWorld Journal of Gastroenterology
researchProduct

High prevalence of human cytomegalovirus in a population of periodontally healthy subjects.

2008

Background: Human cytomegalovirus (HCMV) appears to be more frequent in periodontally affected patients than in healthy control groups. Based on this assumption, it has been suggested that HCMV may play a role in the pathogenesis of periodontal disease. Objective: The objective of this uncontrolled study was to assess the occurrence of HCMV in a large unselected population of periodontally healthy subjects. Study Design: Fifty consecutive periodontally healthy patients satisfied the inclusion criteria. Two samples of gingival crevicular fluids were taken from two non-bleeding on probing sites for each patient. Samples were collected from the anterior and the posterior area. Polymerase chain…

AdultMaleHuman cytomegalovirusmedicine.medical_specialtyvirusesPopulationGingivaCytomegalovirusDentistryGastroenterologyPathogenesisYoung AdultInternal medicinePrevalencemedicineHumansYoung adulteducationGeneral Dentistryeducation.field_of_studyHigh prevalencebusiness.industryHealthy subjectsvirus diseasesMiddle Agedbiochemical phenomena metabolism and nutrition:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDrinking habitsOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASGingival Crevicular FluidsFemaleSurgerybusiness
researchProduct

Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Stu…

2016

International audience;  Although an isolated anti-hepatitis B virus (HBV) core antibody (anti-HBc) serological profile is frequent in human immunodeficiency virus (HIV)-infected patients, data on HBV vaccination in these patients are scarce.  A prospective multicenter study was conducted to assess the immunogenicity of HBV vaccination in 54 patients with an isolated anti-HBc profile and undetectable HIV load. They were vaccinated with 1 dose (20 µg) of recombinant HBV vaccine. Those with an anti-HBV surface antibody (anti-HBs) level of 100 mIU/mL 4 weeks after a single recall dose of HBV vaccine should be further vaccinated with a reinforced triple double-dose scheme.

AdultMaleHuman immunodeficiency virus (HIV)HIV Infectionsmedicine.disease_causeVirusSerology03 medical and health sciences0302 clinical medicineImmunogenicity Vaccine[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyAntiretroviral Therapy Highly ActiveHepatitis B virus HBVImmunology and AllergyMedicineHumansHepatitis B Vaccines030212 general & internal medicineProspective StudiesHepatitis B AntibodiesProspective cohort study[SDV.MP] Life Sciences [q-bio]/Microbiology and ParasitologyVaccines Syntheticbiologybusiness.industryImmunogenicityvirus diseasesMiddle AgedHepatitis BVirologyHepatitis B Core Antigensdigestive system diseasesVaccinationInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyImmunologybiology.proteinHIV-1030211 gastroenterology & hepatologyFemaleAntibodybusiness
researchProduct

Validation of the German version of the ‘Hypogonadism Related Symptom Scale’ (HRS) in andrological patients with infertility, HIV infection and metab…

2013

Summary As commonly used self-reported screening instruments for male hypogonadism demonstrated lack of specificity, a Hypogonadism Related Symptom Scale (HRS) was developed in 2009 as a novel self-rating screening tool. As the questionnaire has not been validated, the purpose of our study was to perform a validation in patients presenting with different disorders (e.g. infertility, HIV infection or metabolic syndrome) and disease-related risk to develop hypogonadism. Two hundred and eighteen patients aged 19–71 years (40.1 ± 9.5) who completed the HRS and other common questionnaires [International Index Of Erectile Function (IIEF), National Institutes of Health Chronic Prostatitis Symptom …

AdultMaleInfertilitymedicine.medical_specialtyUrologyHuman immunodeficiency virus (HIV)ProstatitisHIV Infectionsmedicine.disease_causeHospital Anxiety and Depression ScaleSensitivity and SpecificitySeverity of Illness IndexYoung AdultEndocrinologyCronbach's alphaSex Hormone-Binding GlobulinSurveys and QuestionnairesInternal medicinemedicineHumansTestosteroneAgedMetabolic SyndromeGynecologybusiness.industryHypogonadismTestosterone (patch)General MedicineLuteinizing HormoneMiddle Agedmedicine.diseaseFollicle Stimulating HormoneSymptom AssessmentMetabolic syndromeLuteinizing hormonebusinessAndrologia
researchProduct

Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin

2012

It is unclear whether the current threshold for 'high' hepatitis C virus (HCV) RNA level (800,000 IU/mL) is optimal for predicting sustained virological response (SVR). We retrospectively analysed pretreatment HCV RNA levels and SVR rates in 1529 mono-infected and 176 HIV-HCV co-infected patients treated with peginterferon alfa-2a (40 kD) plus ribavirin. We improved the threshold for differentiating low and high viral load by fitting semiparametric generalized additive logistic regression models to the data and constructing receiver operating characteristics curves. Among HCV genotype 1 mono-infected patients, the difference in SVR rates between those with low and high baseline HCV RNA leve…

AdultMaleInterferon-alphaAlanine TransaminaseHepacivirusMiddle AgedViral LoadAntiviral AgentsHepatitis CRecombinant ProteinsPolyethylene GlycolsLogistic ModelsTreatment OutcomeROC CurveRibavirinHumansRNA ViralDrug Therapy CombinationFemalehepatitis CRetrospective Studies
researchProduct

[Investigation of an outbreak of norovirus gastroenteritis in a geriatric hospital]

2005

National audience; In aged-care facilities, gastroenteritis outbreaks are responsible for big trouble in the management of cares to the elderly. In November 2002, a gastroenteritis outbreak was observed in 5 of the 6 wards of the geriatric hospital La Charité, University Hospital of Saint-Etienne, France, with an attack rate of 38.5% in the elderly (70 infected from 182 patients) and of 26.0% in the nursing staff (40 infected from 154 agents). The outbreak lasted 30 days with a peak corresponding to 79.8% of the cases between the 11(th) and the 20(th) of November. The first cases were observed in the two short-term-care wards; then, the outbreak spread rapidly to 3 of the 4 long-term care u…

AdultMaleMESH: NorovirusMESH : MaleMESH : Hospitals SpecialMESH : AgedMESH: GeriatricsHospitals Special[ SDV.MP.VIR ] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyDisease OutbreaksMESH: Aged 80 and overHumansMESH : Middle AgedMESH : Disease OutbreaksMESH : FemaleMESH: Disease OutbreaksMESH : Aged 80 and overMESH : GeriatricsMESH: Caliciviridae InfectionsAgedCaliciviridae InfectionsAged 80 and overMESH: Aged[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyMESH: Middle AgedMESH: HumansMESH : NorovirusNorovirusMESH : HumansMESH: Hospitals SpecialMESH: AdultMiddle AgedMESH : AdultMESH: MaleMESH: GastroenteritisGastroenteritisMESH : GastroenteritisGeriatrics[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyFemaleMESH : Caliciviridae InfectionsMESH: Female
researchProduct

The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies

1999

Abstract Background/Aims: Cytotoxic T lymphocytes have been demonstrated in peripheral blood and liver tissue of patients with chronic hepatitis C virus infection, but their significance for viral clearance is unknown. Therefore, we analyzed hepatitis C virus-specific cytotoxic T lymphocyte precursor frequencies in chronic hepatitis C virus carriers during interferon-α treatment. Methods: Blood mononuclear cells or CD8+ T cells from HLA-A2 positive and negative patients and controls were analyzed in chromium-release assays using a panel of 18 synthetic peptides from the HCV core, E1 and NS4 antigens bearing HLA-A2 binding motifs. Specific cytotoxic T lymphocyte precursor frequencies were st…

AdultMaleMetabolic Clearance RateHepatitis C virusBiologymedicine.disease_causeAntiviral AgentsAntigenInterferonHLA-A2 AntigenmedicineHumansCytotoxic T cellHepatologyELISPOTInterferon-alphaHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseVirologyTreatment OutcomeCase-Control StudiesImmunologyFemaleViral loadCD8T-Lymphocytes Cytotoxicmedicine.drugJournal of Hepatology
researchProduct